Bumimedic has an agreement with Amarillo Biosciences USA to develop the low dose Interferon Alpha Lozenges (natural human IFN) for various therapeutic indications. Under the license and supply agreement, Bumimedic acquired the rights to manufacture and distribute the oral dose IFN products in Malaysia. Worldwide clinical trials are in progress.
Bumimedic is the distributor for Dutch Lady for a range of specially formulated diary based nutritional products mainly for the infants and Geriatric patients who are under medical care at the private and governmental hospitals.
The company manages the logistics for MySMO, one of the most highly sought after Clinical Research Organization in Malaysia.
MySMO has successfully carried out several studies with pharmaceutical and medical device companies and it covers phase II-IV drug development of clinical trials in various disciplines including therapeutic areas such as Stem Cells, Oncology, Psychiatry, Diabetes, Orthopedics, Cardiovascular and Nephrology. |
